2011
DOI: 10.1038/leu.2011.30
|View full text |Cite
|
Sign up to set email alerts
|

HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
18
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 11 publications
1
18
1
Order By: Relevance
“…Previous reports have suggested that homozygosity of HLA is associated with the development of CLL 41,42 and DLCBL, 43 which we also report for all HLA class I loci. Although consanguinity among cases cannot be formally assessed, it would not account for the magnitude of this observed risk (OR 5 1.16-1.19).…”
Section: Discussionsupporting
confidence: 56%
See 1 more Smart Citation
“…Previous reports have suggested that homozygosity of HLA is associated with the development of CLL 41,42 and DLCBL, 43 which we also report for all HLA class I loci. Although consanguinity among cases cannot be formally assessed, it would not account for the magnitude of this observed risk (OR 5 1.16-1.19).…”
Section: Discussionsupporting
confidence: 56%
“…However, a recent CLL association result from MD Anderson indicated that the A1;C7;B8 haplotype was predisposing for CLL. 41 We note the MD Anderson dataset included only patients that proceeded to allogeneic transplant, which likely biases cases toward more common HLA alleles, whereas the NMDP dataset included patients that did not identify a matched donor and/or did not proceed to transplant.…”
Section: Discussionmentioning
confidence: 99%
“…A bias in HLA usage, mainly concerning the development of severe disease, was reported in CLL. [26][27][28] In addition, a very recent study associated HLA specificities with prognosis in MBL, 29 pointing to the existence of protective HLA-restricted T cell interactions involved in the control of tumor expansion. In line with this, two of our MBL cases with a shared TR CDR3 region also shared five of the eight analyzed HLA loci.…”
Section: Discussionmentioning
confidence: 99%
“…HLA homozygosity could provide a selective advantage to neoplastic cells by restricting the potential of presentation of tumor-specific epitopes by HLA antigens. Interestingly, a recent study 19 has reported a slightly increased homozygosity rate at HLA-A, B, C, DRB1 loci in a large cohort of chronic lymphocytic leukemia patients compared with HLA allele distribution in the population. Copy-neutral LOH at 6p arms has recently been observed in 13% aplastic anemia patients, all involving the HLA region.…”
Section: Discussionmentioning
confidence: 97%